Stock Comparison

UNH vs WVE

UnitedHealth Group Inc vs WAVE Life Sciences Ltd

The Verdict

WVE takes this one.

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Winner

WVE

WAVE Life Sciences Ltd

6.9

out of 10

Solid Pick

Head-to-Head

$365.5B

Market Cap

$1.1B

30.3

P/E Ratio

N/A

2.7%

Profit Margin

-255.7%

12.4%

Return on Equity

-55.7%

0.8

Debt-to-Equity

N/A

Moderate

Overall Risk

Aggressive

0.3

DVR Score

6.9

The Deep Dive

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

WVE6.9/10

WAVE Life Sciences continues to present a high-risk, high-reward profile, with its score remaining consistent due to no new material changes since the last analysis, although Q1 2026 EPS beat estimates. The company's 10x growth potential hinges on the successful progression and potential accelerated approval of WVE-006 for alpha-1 antitrypsin deficiency (AATD), supported by recent positive RestorA...

Full WVE Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.